Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Soriano JB, Abajobir AA, Abate KH; Collaborators GCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691. doi:10.1016/S2213-2600(17)30293-X
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251–272. doi:10.1016/S0140-6736(15)00551-6
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] Study): a National Cross-Sectional Study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353. doi:10.2147/COPD.S161555
   PubMed Web of Science ®Google Scholar
• European respiratory society on behalf of the forum of international respiratory societies(FIRS). The global impact of respiratory disease, second edition; 2017. Available from: https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf. Accessed April 8, 2021.
   Google Scholar
• Izquierdo J. The burden of COPD in Spain: results from the confronting COPD survey. Respir Med. 2003;97:S61–S69. doi:10.1016/S0954-6111(03)80026-4
   PubMed Web of Science ®Google Scholar
• Britton M. The burden of COPD in the UK: results from the confronting COPD survey. Respir Med. 2003;97:S71–S79. doi:10.1016/S0954-6111(03)80027-6
   PubMed Web of Science ®Google Scholar
• Bi-jun S, Tao Z, Jun C, Yong W, Hui L. Direct economic burden of 803 patients with chronic obstructive pulmonary disease and influencing factors in Ningbo. Dis Surveill. 2015;30(4):300–304.
   Google Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):4. doi:10.1378/chest.128.4.2005
   Web of Science ®Google Scholar
• Soler-Cataluna J, Martínez-García MÁ, Sánchez PR, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Li M, Wang F, Chen R, et al. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data. Int J Chron Obstruct Pulmon Dis. 2018;13:3349. doi:10.2147/COPD.S175143
   PubMed Web of Science ®Google Scholar
• Dang-Tan T, Zhang S, Tavares RV, et al. The burden of illness related to chronic obstructive pulmonary disease exacerbations in Québec, Canada. Can Respir J. 2017;2017:1–10. doi:10.1155/2017/8184915
   Web of Science ®Google Scholar
• Alqahtani JS, Njoku CM, Bereznicki B, et al. Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(156):156. doi:10.1183/16000617.0166-2019
   Web of Science ®Google Scholar
• Luo L, Lian S, Feng C, Huang D, Zhang W. Data mining-based detection of rapid growth in length of stay on COPD patients. IEEE. 2017;254–258.
   Google Scholar
• Agboado G, Peters J, Donkin L. Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a Cross-Sectional Study. BMJ Open. 2012;2(5):5. doi:10.1136/bmjopen-2012-000869
   Web of Science ®Google Scholar
• Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM. Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit. ERJ Open Res. 2016;2(1):00034–2015. doi:10.1183/23120541.00034-2015
   PubMedGoogle Scholar
• Global initiative for chronic Obstructive Lung Disease (GOLD) Committee. Global strategy for the diagnosis, management, and prevention of COPD; 2020. Available from: https://goldcopd.org/2021-gold-reports/. Accessed April 8, 2021.
   Google Scholar
• Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502. doi:10.1016/j.mayocp.2018.05.026
   PubMed Web of Science ®Google Scholar
• Montuschi P. Pharmacological treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2006;1(4):409–423. doi:10.2147/copd.2006.1.4.409
   PubMedGoogle Scholar
• Government of Macao Special Administrative Region. Statistics and census service survey on manpower needs and wages – gaming industry; 2014. Available from: http://www.dsec.gov.mo/Statistic.aspx?NodeGuid=6289ca07-25cc-450b-8499-4e34765c1769. Accessed 8 April, 2021.
   Google Scholar
• Ng WI, Smith GD. Effects of a self-management education program on self-efficacy in patients with COPD: a mixed-methods sequential explanatory designed study. Int J Chron Obstruct Pulmon Dis. 2017;12:2129. doi:10.2147/COPD.S136216
   PubMed Web of Science ®Google Scholar
• Wikipedia. Kiang Wu Hospital; 2020. Available from: https://en.wikipedia.org/wiki/Kiang_Wu_Hospital. Accessed April 8, 2021.
   Google Scholar
• Austin D, Pouliquen I, Yancey S, Bleeker E. A blood eosinophil count of greater than 150 cells/uL predicts sputum eosinophilia ≥ 3% in patients with severe asthma with other markers of inflammatory lung disease. In: B101 Phenotyping of Asthma in the Era of Biomarkers and Omics. American Thoracic Society; 2016:A4338–A4338.
   Google Scholar
• Kostikas K, Brindicci C, Patalano F. Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD. Curr Drug Targets. 2018;19(16):1882–1896. doi:10.2174/1389450119666180212120012
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care. 2011;56(5):644–652. doi:10.4187/respcare.01002
   PubMed Web of Science ®Google Scholar
• Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–1750. doi:10.1182/blood-2005-07-3046
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. doi:10.1164/rccm.201110-1792OC
   PubMed Web of Science ®Google Scholar
• Afzal A, Heyes K, Baksi S, Khalid S. P254 Association of Low Serum Creatinine and Mortality in COPD. BMJ Publishing Group Ltd; 2019.
   Google Scholar
• NHS. Overview of blood tests. Available from: https://www.nhs.uk/conditions/blood-tests/. Accessed April 8, 2021.
   Google Scholar
• Chronic Obstructive Pulmonary Disease Group RDB, Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of chronic obstructive pulmonary diseases (revised 2013). Chin J Med Sci. 2014;6(2):67–80.
   Google Scholar
• Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. Chronic Obstr Pulm Dis. 2012;9(2):131–141. doi:10.3109/15412555.2011.650239
   Web of Science ®Google Scholar
• Jinjuvadia C, Jinjuvadia R, Mandapakala C, Durairajan N, Liangpunsakul S, Soubani AO. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. Chronic Obstr Pulm Dis. 2017;14(1):72–79. doi:10.1080/15412555.2016.1199669
   Web of Science ®Google Scholar
• Health Bureau of Macao Special Administrative Region. Average life expectancy of the population; 2020. Available from: https://www.ssm.gov.mo/portal/. Accessed April 8, 2021.
   Google Scholar
• Region GoMSA. Macau Population Policy Research Report. 2015.
   Google Scholar
• Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163(10):1180–1186. doi:10.1001/archinte.163.10.1180
   PubMed Web of Science ®Google Scholar
• Connolly MJ, Lowe D, Anstey K, Hosker H, Pearson M, Roberts C. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax. 2006;61(10):843–848. doi:10.1136/thx.2005.054924
   PubMed Web of Science ®Google Scholar
• George P, Stone R, Buckingham R, Pursey N, Lowe D, Roberts C. Changes in NHS organization of care and management of hospital admissions with COPD exacerbations between the national COPD audits of 2003 and 2008. QJM. 2011;104(10):859–866. doi:10.1093/qjmed/hcr083
   PubMed Web of Science ®Google Scholar
• Franssen FM, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur Respir Rev. 2014;23(131):131–141. doi:10.1183/09059180.00007613
   PubMedGoogle Scholar
• Negewo NA, McDonald VM, Gibson PG. Comorbidity in chronic obstructive pulmonary disease. Respir Investig. 2015;53(6):249–258. doi:10.1016/j.resinv.2015.02.004
   PubMed Web of Science ®Google Scholar
• Baty F, Putora PM, Isenring B, Blum T, Brutsche M. Comorbidities and burden of COPD: a Population Based Case-Control Study. PLoS One. 2013;8(5):e63285. doi:10.1371/journal.pone.0063285
   PubMed Web of Science ®Google Scholar
• de Miguel-díez J, Morgan JC, García J-G. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305. doi:10.2147/COPD.S31236
   PubMed Web of Science ®Google Scholar
• Wang Y, Stavem K, Dahl FA, Humerfelt S, Haugen T. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014;9:99. doi:10.2147/COPD.S51467
   PubMed Web of Science ®Google Scholar
• Inabnit LS, Blanchette C, Ruban C. Comorbidities and length of stay in chronic obstructive pulmonary disease patients. Chronic Obstr Pulm Dis. 2018;15(4):355–360. doi:10.1080/15412555.2018.1513470
   Web of Science ®Google Scholar
• Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.00111707
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362(3):217–227. doi:10.1056/NEJMoa0808836
   PubMed Web of Science ®Google Scholar
• Janssen DJ, Spruit MA, Uszko-Lencer NH, Schols JM, Wouters EF. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med. 2011;14(6):735–743. doi:10.1089/jpm.2010.0479
   PubMed Web of Science ®Google Scholar
• Lanken PN, Terry PB, DeLisser HM, et al. An official American thoracic society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–927. doi:10.1164/rccm.200605-587ST
   PubMed Web of Science ®Google Scholar
• Taylor RS, Sagar VA, Davies EJ, et al. Exercise‐based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014;(4). doi:10.1002/14651858.CD003331.pub4
   Web of Science ®Google Scholar
• Jayadev A, Stone R, Steiner MC, McMillan V, Roberts CM. Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from national COPD audits. BMJ Open Respir Res. 2019;6(1):e000444. doi:10.1136/bmjresp-2019-000444
   PubMed Web of Science ®Google Scholar
• Stefan M, Priya A, Pekow P, et al. The association between pulmonary rehabilitation and rehospitalizations in patients with COPD. In: A94 Expanding Our Horizons; Leading Research in Pulmonary Rehabilitation: 2020. American Thoracic Society; 2020:A2503–A2503.
   Google Scholar
• Ambrosino N, Vagheggini G. Non-invasive ventilation in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(4):471.
   PubMedGoogle Scholar
• Rai S, Panda B, Upadhyay K. Noninvasive positive pressure ventilation in patients with acute respiratory failure. Med J Armed Forces India. 2004;60(3):224–226. doi:10.1016/S0377-1237(04)80050-9
   PubMedGoogle Scholar
• Kaul S, Pearson M, Coutts I, Lowe D, Roberts M. Non-invasive ventilation (NIV) in the clinical management of acute COPD in 233 UK hospitals: results from the RCP/BTS 2003 national COPD audit. Chronic Obstr Pulm Dis. 2009;6(3):171–176. doi:10.1080/15412550902902646
   Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64. doi:10.1164/rccm.201309-1634ST
   PubMed Web of Science ®Google Scholar
• Katajisto M, Laitinen T. Estimating the effectiveness of pulmonary rehabilitation for COPD exacerbations: reduction of hospital inpatient days during the following year. Int J Chron Obstruct Pulmon Dis. 2017;12:2763. doi:10.2147/COPD.S144571
   PubMed Web of Science ®Google Scholar
• Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest. 2003;124(1):94–97. doi:10.1378/chest.124.1.94
   PubMed Web of Science ®Google Scholar
• Zeng Y, Jiang F, Chen Y, Chen P, Cai S. Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. Int J Chron Obstruct Pulmon Dis. 2018;13:2013. doi:10.2147/COPD.S167098
   PubMed Web of Science ®Google Scholar
• Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J. 2011;20(2):199–204. doi:10.4104/pcrj.2011.00011
   PubMedGoogle Scholar
• George J, Kong DC, Stewart K. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(3):253.
   PubMedGoogle Scholar
• Hu G, Zhou Y, Tian J, et al. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010;138(1):20–31. doi:10.1378/chest.08-2114
   PubMed Web of Science ®Google Scholar
• Taylor JD. COPD and the response of the lung to tobacco smoke exposure. Pulm Pharmacol Ther. 2010;23(5):376–383. doi:10.1016/j.pupt.2010.04.003
   PubMed Web of Science ®Google Scholar
• Halpern MT, Stanford R, Borker R. The burden of COPD in the USA: results from the confronting COPD survey. Respir Med. 2003;97:S81–S89. doi:10.1016/S0954-6111(03)80028-8
   PubMed Web of Science ®Google Scholar
• Tønnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37–43. doi:10.1183/09059180.00007212
   PubMedGoogle Scholar
• Rezaei S, Akbari Sari A, Arab M, Majdzadeh R, Shaahmadi F, Mohammadpoorasl A. The association between smoking status and hospital length of stay: evidence from a hospital-based cohort. Hosp Pract. 2016;44(3):129–132. doi:10.1080/21548331.2016.1178579
   Google Scholar
• Azagba S, Sharaf MF, Liu CX. Disparities in health care utilization by smoking status in Canada. Int J Public Health. 2013;58(6):913–925. doi:10.1007/s00038-013-0452-7
   PubMed Web of Science ®Google Scholar
• Wacker M, Holle R, Heinrich J, et al. The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study. BMC Health Serv Res. 2013;13(1):278. doi:10.1186/1472-6963-13-278
   PubMed Web of Science ®Google Scholar
• Bai J, Chen X, Liu S, Yu L, Xu J. Smoking cessation affects the natural history of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:3323. doi:10.2147/COPD.S150243
   PubMed Web of Science ®Google Scholar